Evolent Health Inc Class A Forecast, price target & analysts
Evolent Health Inc Class A Target price 2026 - Analyst rating & recommendation
Evolent Health Inc Class A Classifications & Recommendation
Evolent Health Inc Class A Price Target
| Target Price | $6.12 |
| Price | $3.65 |
| Potential |
67.67%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Evolent Health Inc Class A 2027 .
The average Evolent Health Inc Class A target price is $6.12.
This is
67.67%
register free of charge
$15.75
331.51%
register free of charge
$3.03
16.99%
register free of charge
|
|
| A rating was issued by 19 analysts: 15 Analysts recommend Evolent Health Inc Class A to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Evolent Health Inc Class A stock has an average upside potential 2027 of
67.67%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.88 | 2.65 |
| 26.56% | 41.45% | |
| EBITDA Margin | 5.59% | 4.86% |
| 23.37% | 13.09% | |
| Net Margin | -30.88% | 0.83% |
| 744.23% | 102.69% |
17 Analysts have issued a sales forecast Evolent Health Inc Class A 2026 . The average Evolent Health Inc Class A sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an Evolent Health Inc Class A EBITDA forecast 2026. The average Evolent Health Inc Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 Evolent Health Inc Class A Analysts have issued a net profit forecast 2026. The average Evolent Health Inc Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -5.07 | 0.20 |
| 525.93% | 103.94% | |
| P/E | 18.72 | |
| EV/Sales | 0.48 |
17 Analysts have issued a Evolent Health Inc Class A forecast for earnings per share. The average Evolent Health Inc Class A EPS is
This results in the following potential growth metrics and future valuations:
Evolent Health Inc Class A...
Current Evolent Health Inc Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 18 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 17 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jul 28 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 18 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 17 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jul 28 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Jul 23 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
